Trial · NCT00769704
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Durable Response Rate | GM-CSF | 2.1 | 95% Confidence Interval 0.0 to 4.5 | percentage of participants | |
| Durable Response Rate | Talimogene Laherparepvec | 16.3 | 95% Confidence Interval 12.1 to 20.5 | percentage of participants | |
| Overall Survival | GM-CSF | 18.9 | 95% Confidence Interval 16.0 to 23.7 | months | |
| Overall Survival | Talimogene Laherparepvec | 23.3 | 95% Confidence Interval 19.5 to 29.6 | months | |
| Objective Response Rate | GM-CSF | 5.7 | 95% Confidence Interval 1.9 to 9.5 | percentage of participants | |
| Objective Response Rate | Talimogene Laherparepvec | 26.4 | 95% Confidence Interval 21.4 to 31.5 | percentage of participants | |
| Duration of Response | GM-CSF | 2.8 | 95% Confidence Interval 1.2 to NA | months | |
| Duration of Response | Talimogene Laherparepvec | NA | 95% Confidence Interval NA to NA | months | |
| Response Onset | GM-CSF | 3.7 | 95% Confidence Interval 1.9 to 5.6 | months | |
| Response Onset | Talimogene Laherparepvec | 4.1 | 95% Confidence Interval 3.8 to 5.4 | months | |
| Time to Treatment Failure | GM-CSF | 2.9 | 95% Confidence Interval 2.8 to 4.0 | months | |
| Time to Treatment Failure | Talimogene Laherparepvec | 8.2 | 95% Confidence Interval 6.5 to 9.9 | months | |
| Response Interval | GM-CSF | 7.5 | 95% Confidence Interval 1.9 to NA | months | |
| Response Interval | Talimogene Laherparepvec | NA | 95% Confidence Interval NA to NA | months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00769704/results